English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/4304
Compartir / Impacto:
Add this article to your Mendeley library MendeleyBASE
Citado 15 veces en Web of Knowledge®  |  Ver citas en Google académico
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar otros formatos: Exportar EndNote (RIS)Exportar EndNote (RIS)Exportar EndNote (RIS)
Título : Murine models to investigate the influence of diabetic metabolism on the development of atherosclerosis and restenosis
Autor : González-Navarro, Herminia ; Burks, Deborah J.; Andrés, Vicente
Palabras clave : Atherosclerosis
Diabetes Mellitus
Metabolic Syndrome
Genetically-Modified Mice
Insulin Resistance
Chronic Inflammation
Fecha de publicación : may-2007
Editor: Frontiers in Bioscience Publications
Citación : Frontiers in Bioscience 12, 4439-4455
Resumen: Atherosclerosis and related forms of cardiovascular disease (CVD) are associated with several genetic and environmental risk factors, including hypercholesterolemia, diabetes mellitus (DM), hypertension, obesity and smoking. Human DM is a multisystem disorder that results from progressive failure of insulin production and insulin resistance. Most diabetic patients die from complications of atherosclerosis and CVD, and DM is also associated with increased risk of restenosis post-angioplasty. Furthermore, the incidence of DM, particularly type 2-DM, is expected to increase significantly during the next decades owing to the unhealthy effects of modern life-style habits (e.g., obesity and lack of physical exercise). Thus, it is of utmost importance to develop novel preventive and therapeutic strategies to reduce the social and health-care burden of CVD and DM. Although a number of physiological alterations thought to promote atherosclerosis have been identified in diabetic patients, the precise molecular mechanisms that link DM and atherosclerosis are largely unknown. Thus, the aim of this review is to discuss current murine models of combined DM and atherosclerosis and to explore how these experimental systems are being utilized to gain mechanistic insights into diabetes-induced neointimal lesion development, as well as their potential use in evaluating the efficacy of new therapies. Our discussion includes models generated by streptozotocin treatment and those resulting from naturally occurring or targeted mutations in the mouse.
Descripción : This is an, un-copyedited, author manuscript that has been accepted for publication in the Frontiers in Bioscience
URI : http://hdl.handle.net/10261/4304
DOI: 10.2741/2400
Aparece en las colecciones: (IBV) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
Front Biosci 012-04439.pdf246,21 kBAdobe PDFVista previa
Mostrar el registro completo

NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.